Alpha 2.0
Login Register
» Authors » Yasuhiro Hisanaga

Yasuhiro Hisanaga

Explore the profile of Yasuhiro Hisanaga including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 54
Citations 578
Followers 0
Related Specialties
Gastroenterology
Microbiology
Oncology
Top 10 Co-Authors
Takashi Kumada
Hidenori Toyoda
Seiki Kiriyama
Makoto Tanikawa
Akira Kanamori
Yasuhiro Sone
Toshifumi Tada
Shusuke Kitabatake
Takahiro Arakawa
Masashi Fujimori
Published In
J Gastroenterol Hepatol
J Med Virol
J Gastroenterol
Liver Int
Hepatol Res
Affiliations
Soon will be listed here.
Recent Articles
1.
Long-term Survival After Endoscopic Resection For Gastric Cancer: Real-world Evidence From a Multicenter Prospective Cohort
Suzuki H, Ono H, Hirasawa T, Takeuchi Y, Ishido K, Hoteya S, et al.
Clin Gastroenterol Hepatol . 2022 Aug; 21(2):307-318.e2. PMID: 35948182
Background & Aims: We aimed to clarify the long-term outcomes of endoscopic resection (ER) for early gastric cancers (EGCs) based on pathological curability in a multicenter prospective cohort study. Methods:...
2.
Impact of COVID-19 pandemic on surveillance of hepatocellular carcinoma: A study in patients with chronic hepatitis C after sustained virologic response
Toyoda H, Yasuda S, Kiriyama S, Tanikawa M, Hisanaga Y, Kanamori A, et al.
GastroHep . 2020 Aug; 2(5):247-252. PMID: 32837333
Background: The current coronavirus disease 2019 (COVID-19) pandemic has strongly influenced many aspects of the medical care, including cancer surveillance. Aims: We investigated how the COVID-19 pandemic influenced surveillance for...
3.
Self-study of the non-extension sign in an e-learning program improves diagnostic accuracy of invasion depth of early gastric cancer
Kato M, Uedo N, Nagahama T, Yao K, Doyama H, Tsuji S, et al.
Endosc Int Open . 2019 Jul; 7(7):E871-E882. PMID: 31286056
 We developed an e-learning program for endoscopic diagnosis of invasion depth of early gastric cancer (EGC) using a simple diagnostic criterion called non-extension sign, and the contribution of self-study quizzes...
4.
Post-treatment levels of α-fetoprotein predict long-term hepatocellular carcinoma development after sustained virological response in patients with hepatitis C
Tada T, Kumada T, Toyoda H, Kiriyama S, Tanikawa M, Hisanaga Y, et al.
Hepatol Res . 2016 Nov; 47(10):1021-1031. PMID: 27859993
Aim: The rate of hepatocellular carcinoma (HCC) development is reportedly lower in patients with chronic hepatitis C virus (HCV) who have achieved a sustained virological response (SVR) than in patients...
5.
Viral eradication reduces all-cause mortality, including non-liver-related disease, in patients with progressive hepatitis C virus-related fibrosis
Tada T, Kumada T, Toyoda H, Kiriyama S, Tanikawa M, Hisanaga Y, et al.
J Gastroenterol Hepatol . 2016 Sep; 32(3):687-694. PMID: 27577675
Background And Aim: Eradication of hepatitis C virus (HCV) with interferon (IFN)-based therapy has been reported to reduce all-cause mortality in patients with chronic HCV infection. However, the impact of...
6.
HBcrAg predicts hepatocellular carcinoma development: An analysis using time-dependent receiver operating characteristics
Tada T, Kumada T, Toyoda H, Kiriyama S, Tanikawa M, Hisanaga Y, et al.
J Hepatol . 2016 Apr; 65(1):48-56. PMID: 27034253
Background & Aims: Several hepatitis B virus (HBV) markers have been identified as factors associated with the development of hepatocellular carcinoma (HCC) in patients with chronic hepatitis B (CHB). We...
7.
Long- and short-term outcomes of ERCP for bile duct stones in patients over 80 years old compared to younger patients: a propensity score analysis
Kanamori A, Kiriyama S, Tanikawa M, Hisanaga Y, Toyoda H, Tada T, et al.
Endosc Int Open . 2016 Jan; 4(1):E83-90. PMID: 26793790
Unlabelled: Backgrounds and study aims: Endoscopic sphincterotomy (ES) is widely accepted as first-line therapy for bile duct stones (BDS). The major long-term pancreaticobiliary complication is BDS recurrence. Whether cholecystectomy should...
8.
Viral eradication reduces all-cause mortality in patients with chronic hepatitis C virus infection: a propensity score analysis
Tada T, Kumada T, Toyoda H, Kiriyama S, Tanikawa M, Hisanaga Y, et al.
Liver Int . 2016 Jan; 36(6):817-26. PMID: 26787002
Background & Aims: Eradication of hepatitis C virus (HCV) by interferon (IFN)-based therapy has been reported to reduce all-cause mortality rates in patients with chronic HCV infection. However, the impact...
9.
Long-term prognosis of patients with chronic hepatitis C who did not receive interferon-based therapy: causes of death and analysis based on the FIB-4 index
Tada T, Kumada T, Toyoda H, Kiriyama S, Tanikawa M, Hisanaga Y, et al.
J Gastroenterol . 2015 Sep; 51(4):380-9. PMID: 26342600
Background: Interferon (IFN)-based therapy has been reported to reduce the liver-related mortality rate in patients with chronic hepatitis C virus (HCV) infection. However, predictors of survival and causes of death,...
10.
Transnasal Endoscope Locked in a Bent Position Causing Difficult Withdrawal
Toyoda H, Kumada T, Hisanaga Y
ACG Case Rep J . 2015 Jul; 1(2):79-81. PMID: 26157831
We report a rare but severe complication of routine transnasal esophagogastroduodenoscopy (EGD). The tip of a transnasal endoscope was locked in a bent position. Since the bent tip was unable...